__NUXT_JSONP__("/drugs/Brivanib_Alaninate", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"649735-63-7",chebiId:"",chemicalFormula:"C22H24FN5O4",definition:"The alaninate salt of a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic activity. Brivanib strongly binds to and inhibits VEGFR2, a tyrosine kinase receptor expressed almost exclusively on vascular endothelial cells; inhibition of VEGFR2 may result in inhibition of tumor angiogenesis, inhibition of tumor cell growth, and tumor regression.",fdaUniiCode:"U2Y5OFN795",identifier:"C53397",preferredName:b,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C1742","C1967"],synonyms:["BMS 582664","BMS-582664","BRIVANIB ALANINATE",b,"brivanib alaninate"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FBrivanib_Alaninate",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Brivanib_Alaninate","Brivanib Alaninate","2021-10-30T13:40:37.983Z")));